{"id":6854,"date":"2017-09-04T00:00:00","date_gmt":"2017-09-03T22:00:00","guid":{"rendered":"https:\/\/fgu.antstudio.dev\/2017\/09\/ustav-organicke-chemie-a-biochemie-a-fyziologicky-ustav-podepsaly-licencni-smlouvu-s-novo-nordisk\/"},"modified":"2024-07-23T11:37:33","modified_gmt":"2024-07-23T09:37:33","slug":"ustav-organicke-chemie-a-biochemie-a-fyziologicky-ustav-podepsaly-licencni-smlouvu-s-novo-nordisk","status":"publish","type":"post","link":"https:\/\/fgu.cas.cz\/en\/2017\/09\/ustav-organicke-chemie-a-biochemie-a-fyziologicky-ustav-podepsaly-licencni-smlouvu-s-novo-nordisk\/","title":{"rendered":"\u00dastav organick\u00e9 chemie a biochemie a Fyziologick\u00fd \u00fastav podepsaly licencn\u00ed smlouvu s&nbsp;Novo Nordisk"},"content":{"rendered":"<p style=\"text-align: justify;\">\u00dastav organick\u00e9 chemie a biochemie AV CR (\u00daOCHB) ve spolupr\u00e1ci s&nbsp;Fyziologick\u00fdm \u00fastavem AV CR (FG\u00da) vyvinul nov\u00e9 l\u00e1tky, kter\u00e9 maj\u00ed pozitivn\u00ed \u00facinky v&nbsp;experiment\u00e1ln\u00edch zv\u00edrec\u00edch modelech obezity ci diabetu typu II. Tyto l\u00e1tky byly vyvinuty v&nbsp;laboratori Dr. Lenky Malet\u00ednsk\u00e9 (\u00daOCHB), kter\u00e1 se se sv\u00fdm t\u00fdmem zamerila na synt\u00e9zu a zkoum\u00e1n\u00ed modifikovan\u00fdch analogu prirozen\u00fdch neuropeptidu. \u00dastavy podepsaly licencn\u00ed smlouvu s&nbsp;v\u00fdznamnou farmaceutickou firmou Novo Nordisk, kter\u00e1 tyto l\u00e1tky bude nad\u00e1le vyv\u00edjet a pripravovat nejprve pro preklinick\u00e9 testy na zv\u00edrec\u00edch modelech, po nich\u017e v&nbsp;pr\u00edpade \u00faspe\u0161nosti budou n\u00e1sledovat testy klinick\u00e9.<\/p>\n<p style=\"text-align: justify;\"><a href=\"https:\/\/www.fgu.cas.cz\/upload\/files\/TISKOV\u00c1 ZPR\u00c1VA-NOVO UOCHB  FGU.pdf\">Tiskov\u00e1 zpr\u00e1va<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u00dastav organick\u00e9 chemie a biochemie AV CR (\u00daOCHB) ve spolupr\u00e1ci s&nbsp;Fyziologick\u00fdm \u00fastavem AV CR (FG\u00da) vyvinul nov\u00e9 l\u00e1tky, kter\u00e9 maj\u00ed pozitivn\u00ed \u00facinky v&nbsp;experiment\u00e1ln\u00edch zv\u00edrec\u00edch modelech obezity ci diabetu typu II. Tyto l\u00e1tky byly vyvinuty v&nbsp;laboratori Dr. Lenky Malet\u00ednsk\u00e9 (\u00daOCHB), kter\u00e1 se se sv\u00fdm t\u00fdmem zamerila na synt\u00e9zu a zkoum\u00e1n\u00ed modifikovan\u00fdch analogu prirozen\u00fdch neuropeptidu. \u00dastavy podepsaly [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":55280,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-6854","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-other"],"acf":[],"_links":{"self":[{"href":"https:\/\/fgu.cas.cz\/en\/wp-json\/wp\/v2\/posts\/6854","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fgu.cas.cz\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fgu.cas.cz\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fgu.cas.cz\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/fgu.cas.cz\/en\/wp-json\/wp\/v2\/comments?post=6854"}],"version-history":[{"count":0,"href":"https:\/\/fgu.cas.cz\/en\/wp-json\/wp\/v2\/posts\/6854\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fgu.cas.cz\/en\/wp-json\/wp\/v2\/media\/55280"}],"wp:attachment":[{"href":"https:\/\/fgu.cas.cz\/en\/wp-json\/wp\/v2\/media?parent=6854"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fgu.cas.cz\/en\/wp-json\/wp\/v2\/categories?post=6854"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fgu.cas.cz\/en\/wp-json\/wp\/v2\/tags?post=6854"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}